These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 27732810)

  • 21. Tolerance to self-antigens in transgenic mice.
    Adams TE
    Mol Biol Med; 1990 Aug; 7(4):341-57. PubMed ID: 2233246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comment on "Reduced T-dependent humoral immunity in CD20-deficient mice".
    Golay J
    J Immunol; 2013 Dec; 191(12):5783. PubMed ID: 24319281
    [No Abstract]   [Full Text] [Related]  

  • 23. Effective response and delayed toxicities of refractory advanced diffuse large B-cell lymphoma treated by CD20-directed chimeric antigen receptor-modified T cells.
    Wang Y; Zhang WY; Han QW; Liu Y; Dai HR; Guo YL; Bo J; Fan H; Zhang Y; Zhang YJ; Chen MX; Feng KC; Wang QS; Fu XB; Han WD
    Clin Immunol; 2014 Dec; 155(2):160-75. PubMed ID: 25444722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pemphigus vulgaris and its active disease mouse model.
    Amagai M
    Curr Dir Autoimmun; 2008; 10():167-81. PubMed ID: 18460885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of pemphigus with rituximab].
    Li J; Zheng HY; Liu YH
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Feb; 31(1):107-10. PubMed ID: 19317073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. T-cell receptors in autoimmune disease.
    Acha-Orbea H
    Immunol Ser; 1993; 59():131-42. PubMed ID: 8461385
    [No Abstract]   [Full Text] [Related]  

  • 27. Adoptive T-cell therapy of B-cell malignancies: conventional and physiological chimeric antigen receptors.
    Liu L; Sun M; Wang Z
    Cancer Lett; 2012 Mar; 316(1):1-5. PubMed ID: 22099879
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A bispecific single-chain antibody fusion protein for targeted depletion of autoreactive B cells via unstimulated human T lymphocytes.
    Zocher M; Baeuerle PA
    Mol Immunol; 2004 Jul; 41(5):511-8. PubMed ID: 15183929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The complement system contributes to the pathology of experimental autoimmune encephalomyelitis by triggering demyelination and modifying the antigen-specific T and B cell response.
    Hundgeburth LC; Wunsch M; Rovituso D; Recks MS; Addicks K; Lehmann PV; Kuerten S
    Clin Immunol; 2013 Mar; 146(3):155-64. PubMed ID: 23352967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CAR-T cells and solid tumors: tuning T cells to challenge an inveterate foe.
    Gilham DE; Debets R; Pule M; Hawkins RE; Abken H
    Trends Mol Med; 2012 Jul; 18(7):377-84. PubMed ID: 22613370
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathogenic IgG antibodies against desmoglein 3 in pemphigus vulgaris are regulated by HLA-DRB1*04:02-restricted T cells.
    Eming R; Hennerici T; Bäcklund J; Feliciani C; Visconti KC; Willenborg S; Wohde J; Holmdahl R; Sønderstrup G; Hertl M
    J Immunol; 2014 Nov; 193(9):4391-9. PubMed ID: 25252957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The TCR-HA, INS-HA transgenic model of autoimmune diabetes: limitations and expectations.
    Apostolou I; Von Boehmer H
    J Autoimmun; 2004 Mar; 22(2):111-4. PubMed ID: 14987738
    [No Abstract]   [Full Text] [Related]  

  • 33. [The immune system].
    Mawas C
    Pathol Biol (Paris); 1989 Feb; 37(2):89-91. PubMed ID: 2469057
    [No Abstract]   [Full Text] [Related]  

  • 34. Disorder of cellular immunity in pemphigus vegetans.
    Hornstein OP; Djawari D; Lukaschek E; Deinlein E
    Acta Derm Venereol; 1980; 60(2):135-38. PubMed ID: 6155019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced T-dependent humoral immunity in CD20-deficient mice.
    Morsy DE; Sanyal R; Zaiss AK; Deo R; Muruve DA; Deans JP
    J Immunol; 2013 Sep; 191(6):3112-8. PubMed ID: 23966626
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple ways to cellular immune tolerance.
    Geenen V; Kroemer G
    Immunol Today; 1993 Dec; 14(12):573-5. PubMed ID: 8305129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Shattuck lecture: Diversity of the immune repertoire and immunoregulation.
    Schwartz RS
    N Engl J Med; 2003 Mar; 348(11):1017-26. PubMed ID: 12637612
    [No Abstract]   [Full Text] [Related]  

  • 38. RIV-9: a mouse IgG3 anti-human CD3 monoclonal antibody with strong antigen modulating and T cell eliminating properties.
    Vaessen LM; Kreeftenberg JG; Heyse P; Leerling MF; Baumgartner D; Hendriks GF; Jutte NH; Weimer W
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1026-7. PubMed ID: 2523112
    [No Abstract]   [Full Text] [Related]  

  • 39. Molecular biology of autoimmune diseases.
    Boitard C
    Schweiz Med Wochenschr Suppl; 1991; 43():58-64. PubMed ID: 1843039
    [No Abstract]   [Full Text] [Related]  

  • 40. Suppression of murine experimental autoimmune hepatitis by T-cell vaccination or immunosuppression.
    Lohse AW; Dienes HP; Meyer zum Büschenfelde KH
    Hepatology; 1998 Jun; 27(6):1536-43. PubMed ID: 9620324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.